FDA approves Cimerli as interchangeable biosimilar to Lucentis
New injectable approved by the FDA The FDA approved Cimerli as a biosimilar to and interchangeable with Lucentis, according to a press release from Coherus BioSciences. The approval confirms that Cimerli…